Carisma Therapeutics Inc. held a Special Meeting of Stockholders on August 5, 2025. During the meeting, stockholders approved an amendment to the Restated Certificate of Incorporation to effect a reverse stock split of the company's issued shares of common stock at a ratio within the range of 1-for-10 to 1-for-50. The exact ratio and timing will be determined by the Board of Directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.